Direct-To-Consumer Advertising

Direct-to-consumer (DTC) advertising refers to one of the marketing strategies in a pharmaceutical industry. As pharmaceutical products directly affect people's lives and health, many industrialized countries ban DTC advertisements; the United States and New Zealand are the only industrialized countries that allow DTC advertising of prescription medicines. However, there is a controversy over whether DTC advertising, as one of the most effective forms of mass communication, should be more regulated than it is now. This debate is ongoing. This research argument, however, contends that people need stronger regulations against many DTC advertisements in the pharmaceutical industry because they are usually manipulative and misleading to people.

It is clear that most DTC advertisements in the pharmaceutical industry easily approach consumers and inject distorted information about drugs into them. DTC advertisements provide clarity in product performance claims, with less reliance on implied benefits (Beltramini 574). Furthermore, DTC advertisements have made a huge impact on public consciousness with constant exposure to their consumers and sell less effective drugs (Lurie 445). Consumers do not recognize the danger of ineffective drugs due to the embellishment of the marketing strategy. Zelnorm, a drug for women with irritable bowel syndrome, is an example of how a highly visible television advertising campaign makes this less effective drug popular. From a pharmaceutical company’s analysis, while 0.1 percent of patients treated with the drug had a heart attack, chest pain, or a stroke and one died, patients taking a placebo had 0.01 percent of these symptoms and none died. Despite inefficiency of the drug, it became a popular treatment for irritable bowel syndrome because of television advertisement campaign; it displays attractive young women whose bellies are inscribed with the catchphrase, "I feel better" (Shuchman 2239). The reason that ineffective drugs, such as Zelnorm, became popular is because most people who have not enough knowledge to evaluate drugs

DTC advertisements aim to persuade that their possibly less effective drugs work better than other drugs rather than to inform consumers of correct information about drugs. The reason that pharmaceutical companies abuse the power of DTC advertising is because the pharmaceutical industry does not have a strong ethical code for advertising; their sales are so obsessed with profits. To solve this problem, policy makers should prohibit indiscreet DTC advertisements on air and fund more informative services about new drugs so that patients could make clever